Literature DB >> 9832263

Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia.

M Pujol1, X Corbella, C Peña, R Pallares, J Dorca, R Verdaguer, A Diaz-Prieto, J Ariza, F Gudiol.   

Abstract

Over the 5-year period from 1990 to 1994, a prospective cohort study was conducted to define the clinical and epidemiological characteristics of ventilator-associated methicillin-resistant Staphylococcus aureus (MRSA) pneumonia acquired during a large-scale outbreak of MRSA infection. Of 2411 mechanically ventilated patients, 347 (14.4%) acquired MRSA, 220 (63.4%) had MRSA positive respiratory tract samples and 41 (18.6%) developed ventilator-associated MRSA pneumonia. The overall attack rate for ventilator-associated MRSA pneumonia was 1.56 episodes/1000 ventilator days, but annual attack rates varied according to the trend of the outbreak (range 4.9-0.2). In comparison with methicillin-sensitive Staphylococcus aureus (MSSA), which was implicated in 98 episodes of ventilator-associated pneumonia, MRSA caused exclusively late-onset ventilator-associated pneumonia, while MSSA caused both early-onset [55 of 98 (56.1%) episodes] and late-onset [43 of 98 (43.8%) episodes] ventilator-associated pneumonia. Logistic regression analysis of all patients with Staphylococcus aureus pneumonia revealed intubation for more than 3 days (odds ratio (OR),1.11; confidence interval (CI):1.03-1.18) and prior bronchoscopy (OR,5.8; CI,1.85-18.19) to be independent variables associated with MRSA pneumonia. The results indicate that MRSA ventilator-associated pneumonia is a frequent complication in intensive care patients, manifesting itself as late-onset pneumonia in patients who have been intubated for prolonged periods and/or have often undergoing previous bronchoscopy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832263     DOI: 10.1007/bf01708344

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Clinical spectrum of ventilator-associated pneumonia caused by methicillin-sensitive Staphylococcus aureus.

Authors:  D Bergmans; M Bonten; C Gaillard; P de Leeuw; F van Tiel; E Stobberingh; S van der Geest
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 2.  Pneumonia due to Staphylococcus aureus infection.

Authors:  B al-Ujayli; D A Nafziger; L Saravolatz
Journal:  Clin Chest Med       Date:  1995-03       Impact factor: 2.878

3.  Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Iwahara; S Ichiyama; T Nada; K Shimokata; N Nakashima
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

4.  Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains.

Authors:  M Pujol; C Peña; R Pallares; J Ariza; J Ayats; M A Dominguez; F Gudiol
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

5.  Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

Authors:  M Pujol; C Peña; R Pallares; J Ayats; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

6.  Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  R L Thompson; I Cabezudo; R P Wenzel
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  Does the bronchoscope propagate infection?

Authors:  U B Prakash
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

8.  Pneumonia due to Staphylococcus aureus during mechanical ventilation.

Authors:  F Espersen; J Gabrielsen
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

9.  Bacteremic Staphylococcus aureus pneumonia.

Authors:  C Watanakunakorn
Journal:  Scand J Infect Dis       Date:  1987

10.  Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital.

Authors:  M A Dominguez; H de Lencastre; J Linares; A Tomasz
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

View more
  9 in total

1.  Gram-Positive Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Incidence and risk factors for ventilator-associated pneumonia after major heart surgery.

Authors:  Javier Hortal; Maddalena Giannella; Maria Jesús Pérez; José Maria Barrio; Manuel Desco; Emilio Bouza; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2009-06-26       Impact factor: 17.440

Review 3.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

4.  A 7-year study of severe hospital-acquired pneumonia requiring ICU admission.

Authors:  Jordi Vallés; Eduard Mesalles; Dolors Mariscal; Ma del Mar Fernández; Rocío Peña; José Luis Jiménez; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

5.  Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors.

Authors:  Lamia Tilouche; Refka Ben Dhia; Sameh Boughattas; Soumaya Ketata; Olfa Bouallegue; Cherifa Chaouch; Noureddine Boujaafar
Journal:  Curr Microbiol       Date:  2021-05-10       Impact factor: 2.188

6.  Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009).

Authors:  Elisabeth Meyer; F Schwab; P Gastmeier
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

7.  Quinupristin-Dalfopristin.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

Review 8.  Attributable cost of methicillin resistance: an issue that is difficult to evaluate.

Authors:  Jean-François Timsit
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 9.  Nosocomial pneumonia : rationalizing the approach to empirical therapy.

Authors:  Gunnar I Andriesse; Jan Verhoef
Journal:  Treat Respir Med       Date:  2006
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.